Interleukin 2 (IL-2) and IL-15 use receptors with the same signaling subunits. New structural data show that the signaling complexes they form are topologically nearly identical, which suggests that other factors are responsible for the distinct signaling properties of these complexes.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy
Nature Communications Open Access 24 October 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wang, X., Lupardus, P., Laporte, S.L. & Garcia, K.C. Annu. Rev. Immunol. 27, 29–60 (2009).
Ring, A.M. et al. Nat. Immunol. 13, 1187–1195 (2012).
Murray, P.J. J. Immunol. 178, 2623–2629 (2007).
Waldmann, T.A. Nat. Rev. Immunol. 6, 595–601 (2006).
Chirifu, M. et al. Nat. Immunol. 8, 1001–1007 (2007).
Olsen, S.K. et al. J. Biol. Chem. 282, 37191–37204 (2007).
Wang, X., Rickert, M. & Garcia, K.C. Science 310, 1159–1163 (2005).
Mortier, E. et al. Immunity 31, 811–822 (2009).
Liparoto S.F. et al. (2002). Biochemistry 41, 2543–2551 (2002).
Mortier, E. et al. J. Biol. Chem. 281, 1612–1619 (2006).
Thomas, C. et al. Cell 146, 621–632 (2011).
Huang, J. et al. Nature 464, 932–936 (2010)
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ikemizu, S., Chirifu, M. & Davis, S. IL-2 and IL-15 signaling complexes: different but the same. Nat Immunol 13, 1141–1142 (2012). https://doi.org/10.1038/ni.2472
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2472
This article is cited by
-
Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy
Nature Communications (2023)
-
Immunological characterization of the early human fracture hematoma
Immunologic Research (2016)